Transcranial Magnetic Stimulator Market Share, Report 2028

report image

Transcranial Magnetic Stimulator (TMS) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Single or Paired Pulse TMS, Repetitive TMS (rTMS)); Age Group (Adults, Children); Application (Research, Diagnostic, Therapeutic), and Geography

Publication Month: Aug 2021 | Report Code: TIPRE00007242 | No. of Pages: 152 | Category: Medical Device | Status: Published

The transcranial magnetic stimulator (TMS) market is projected to reach US$ 2,029.71 million by 2028 from US$ 1,122.22 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.

Neurological disorders affect the brain and nerves of the human body and cause epilepsy and seizures, Parkinson's disease, dementia, autism, Alzheimer's disease, brain tumors, and cerebral palsy, among others. The prevalence of neurological disorders is increasing across the world. According to the Global Burden of Disease Study (GBD) 2017, Alzheimer’s disease and other dementias [2.55 million Disability Adjusted Life Years (DALYs)], stroke [about 3.58 million DALYs], and migraine (about 2.40 million DALYs) were the three most burdensome neurological diseases in the US in terms of a total number of disability-adjusted life.

Further, the Alzheimer's Association estimates that over 6 million Americans have Alzheimer's disease, and the number is projected to reach nearly 13 million by 2050. Transcranial Magnetic Stimulator (TMS) is widely used for the diagnosis and treatment of neurological disorders. For instance, according to BrainsWay Ltd., in April 2021, 100,000 patients across the world were treated with its Deep TMS. Thus, the growing prevalence of neurological disorders drives the growth of the transcranial magnetic stimulator (TMS) market globally. Moreover, depression is one of the mental disorders observed commonly among people worldwide. As per the data published by WHO in January 2020, more than 264 million people of all ages suffer from depression across the world.

Lucrative Regions for Transcranial Magnetic Stimulator (TMS) Market

Lucrative Regions for Transcranial Magnetic Stimulator (TMS) Market

Get more information on this report :

Market Insights

Transcranial magnetic stimulation (TMS) is a noninvasive procedure that helps in treating neurological disorders. In addition, growing technological developments in TMS have increased its applications. Companies operating in the transcranial magnetic stimulator (TMS) market are adopting various strategies such as receiving Food and Drug Administration (FDA) approvals for their innovative products, business partnerships, and raising funds for product development, which propel the market growth.

The following are a few examples of developments:

  • In March 2021, MagVenture introduced the MagVenture Flow Arm—a patent-pending, clinical positioning system—designed to optimize the delivery of MagVenture's FDA-cleared protocols for noninvasive brain stimulation technology for the treatment of major depressive disorder and as an adjunct therapy for obsessive compulsive disorder (OCD).
  • In August 2020, MagVenture TMS Therapy received FDA clearance for the adjunct treatment of OCD. It is the second indication in the US for the Danish medical device company MagVenture.
  • In February 2019, eNeura, Inc., a privately held medical technology company, announced a new 510(k) clearance from FDA. With the clearance, the company claimed that the sTMS is the only migraine product in the US for the treatment of acute and prophylactic migraine headaches in adults and children (12 years and above).

Thus, the active involvement of the global players in the development of transcranial magnetic stimulation and related technologies is expected to support the market growth.

Type-Based Insights

Based on type, the transcranial magnetic stimulator (TMS) market is segmented into single or paired pulse TMS and repetitive TMS (rTMS). In 2021, the single or paired pulse TMS segment held a larger share of the market. However, the repetitive TMS (rTMS) segment is expected to witness a higher CAGR during 2021–2028.

Transcranial Magnetic Stimulator (TMS) Market, by Type – 2021 and 2028

Transcranial Magnetic Stimulator (TMS) Market, by Type – 2021 and 2028

Get more information on this report :

Application-Based Insights

Based on application, the market is segmented into research, diagnostic, and therapeutic. In 2021, the diagnostic segment held the largest share of the market and is expected to grow at the highest CAGR during the coming years.

Strategic Insights

Report Coverage - Transcranial Magnetic Stimulator (TMS) Market
Report CoverageDetails
Market Size Value inUS$ 1,122.22 Million in 2021
Market Size Value byUS$ 2,029.71 Million by 2028
Growth rateCAGR of 8.8% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages152
No. of Tables85
No. of Charts & Figures69
Historical data availableYes
Segments coveredType ); Age Group ; Application , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Companies operating in the transcranial magnetic stimulator (TMS) market emphasize on adopting the strategy of product innovations to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Transcranial Magnetic Stimulator (TMS) Market – Segmentation

By Type

  • Single or Paired Pulse TMS
  • Repetitive TMS (rTMS)

By Age Group

  • Adults
  • Children

By Application

  • Research
  • Diagnostic
  • Therapeutic

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • BrainsWay Ltd
  • Nexstim, Magstim
  • Neuronetics
  • TMS Neuro Solutions
  • MagVenture, Inc.
  • eNeura Inc.
  • Neurosoft
  • MAG & More GmbH

Frequently Asked Questions

Transcranial Magnetic Stimulator (TMS), also referred to us repetitive Transcranial Magnetic Stimulator (rTMS), is a type of brain stimulation in which a changing magnetic field is applied to a specific area of the brain. An electric pulse stimulator is attached to a magnetic coil, which is then connected to the scalp. It is a non-invasive procedure and is used for diagnostic and therapeutic applications.
The factors that are driving and restraining factors that will affect Transcranial Magnetic Stimulator (TMS) market in the coming years. Factors such as rising prevalence of neurological disorders, growing developments in transcranial magnetic stimulation technology are driving the market growth. However, high cost of diagnostic and treatment are likely to hamper the growth of the market.
The Transcranial Magnetic Stimulator (TMS) market majorly consists of the players such as BrainsWay Ltd, Nexstim, Magstim, Neuronetics, TMS Neuro Solutions, MagVenture, Inc., eNeura Inc., Neurosoft, MAG & More GmbH. REMED among others amongst others.
The US is the largest market for Transcranial Magnetic Stimulator (TMS) at a global level. The US is the largest and fastest-growing market for the TMS market. The market growth is attributed to increasing developments of the medical device sector for neuromodulation, significantly rising incidences of neurological disorders among people and growing demand for neuromodulation devices for chronic pain management. In addition, the economic burden to treat neurological disorders is significantly growing in the country. For instance, according to a study published by the American Neurological Association in March 2017, ~US$ 800 billion is spent per year for treating neurological disorders. The cost of treatment affects ~100 million people every year across the country. It is also estimated that the treatment cost of dementia and stroke alone is estimated to reach over US$ 600 billion in 2030.
The global Transcranial Magnetic Stimulator (TMS) market based on type is segmented into Single or paired pulse TMS and Repetitive TMS (rTMS). In 2021, the Single or paired pulse TMS segment held the largest share of the market, by type. The Repetitive TMS (rTMS) segment of Transcranial Magnetic Stimulator (TMS) market is also expected to witness fastest CAGR during 2021 to 2028..
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to large geriatric population, rising numbers of neurological disorders are among the factors expected to drive the market in the region during the forecast period.

The List of Companies - Transcranial Magnetic Stimulator (TMS) Market

  1. BrainsWay Ltd
  2. Nexstim
  3. Magstim
  4. Neuronetics
  5. TMS Neuro Solutions
  6. MagVenture, Inc.
  7. eNeura Inc.
  8. Neurosoft
  9. MAG & More GmbH.
  10. REMED
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Transcranial Magnetic Stimulator (TMS) Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Transcranial Magnetic Stimulator (TMS), thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount